Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus
Autoantibodies develop in autoimmune diseases, cancer, diabetes mellitus (DM), and atherosclerosis-related diseases. However, autoantibody biomarkers have not been successfully examined for diagnosis and therapy.
Source: BMC Endocrine Disorders - Category: Endocrinology Authors: Toshiki Namiki, Minoru Takemoto, Aiko Hayashi, Hiroki Yamagata, Takahiro Ishikawa, Koutaro Yokote, Shu-Yang Li, Masaaki Kubota, Bo-Shi Zhang, Yoichi Yoshida, Tomoo Matsutani, Seiichiro Mine, Toshio Machida, Yoshio Kobayashi, Jiro Terada, Akira Naito & hel Tags: Research Source Type: research
More News: Autoimmune Disease | Cancer | Cancer & Oncology | Diabetes | Diabetes Mellitus | Endocrinology